AHL Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

AHL Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-42,864	Closed	-$2.24M	–	1397
2017 Q3	$2.24M	Sell	42,864 -5,170	-11%	-$288K	0.04%	636
2017 Q2	$2.81M	Buy	48,034 +22,874	+91%	+$1.19M	0.06%	534
2017 Q1	$1.15M	Buy	25,160 +10,988	+78%	+$547K	0.03%	759
2016 Q4	$746K	Buy	14,172 +1,127	+9%	+$54.6K	0.02%	725
2016 Q3	$581K	Sell	13,045 -7,124	-35%	-$309K	0.02%	789
2016 Q2	$769K	Buy	20,169 +3,427	+20%	+$151K	0.04%	504
2016 Q1	$690K	Sell	16,742 -39,479	-70%	-$1.63M	0.04%	480
2015 Q4	$2.73M	Buy	56,221 +44,276	+371%	+$1.97M	0.21%	172
2015 Q3	$478K	Buy	+11,945	New	+$522K	0.08%	397

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AHL Partners's SYNH Position: Q4 2017 in Review

AHL Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 42,864 shares — an estimated $2.24M sold.

AHL Partners first reported a position in SYNH in Q3 2015 and held it in 9 quarters. The position peaked at $2.81M in Q2 2017. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

AHL Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
AHL Partners sold 42,864 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $2.24M.
AHL Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 9 quarters.
AHL Partners's Syneos Health, Inc. Class A Common Stock position peaked at $2.81M in Q2 2017.
194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.